hereditary disease
Natera Revenues Grow 35 Percent in Q4
The company reported $112.4 million in revenues compared to $83.2 million in Q4 2019, beating the average Wall Street estimate of $106.6 million.
German Medical Center to Report Polygenic Risk Scores as Part of Clinical Whole-Genome Testing
Premium
Under the Ge-Med project, University Hospital Tübingen will offer diagnostic whole-genome sequencing for all genetic indications and will include PRS in its reporting.
Twist Bioscience, Victorian Clinical Genetic Services Develop Diagnostic Exome Assay
The assay combines Twist's Human Comprehensive Exome with customized content for rare and inherited diseases from Australia-based VCGS.
Devyser Diagnostics Raises $15.4M Through Private Placement
The Swedish firm will use the proceeds from the private placement to finance its global marketing and sales expansion.
Later this year, the inherited cardiovascular disease clinic also plans to implement a preventive genomics program with polygenic risk score and PGx testing.
Jun 15, 2020
Centogene Q1 Revenues Increase 13 Percent
Jan 22, 2020
Quest Diagnostics Acquires Blueprint Genetics
Oct 3, 2019
Mar 13, 2018
Jan 25, 2018